Creating Awareness: Rothman Orthopaedic Institute Foundation for Opioid Research & Education

Rothman Orthopaedic Institute Foundation for Opioid Research was launched by Rothman Orthopaedic Institute, an internationally recognized orthopaedic practice. The news was announced today.

Rothman Orthopaedic Institute Foundation for Opioid Research & Education plans to raise awareness among the medical communities of the risks and benefits of safe opioid use. The non-profit will provide resources to educate patients, physicians, and legislators regarding safe opioid use and other alternatives to pain management.

The foundation will be launching a Facebook Live event at 7:00 PM on July 28th, 2020 in order to interview the foundation’s president, Dr. Asif Ilyas along with Kelly Doyle, CEO of Rothman Orthopaedic Specialty Hospital. The foundation’s president Dr. Ilyas is an award-winning hand and trauma surgeon at Rothman Orthopaedic Institute. During his tenure as President of the Pennsylvania Orthopaedic Society, Dr. Ilyas, led a state-wide movement using evidence-based medicine to review management policies and strategies to find alternatives to opioid use. Doyle has been working in health care for 24 years and recently earned an Executive Masters in Healthcare Leadership from Brown University. She was also recognized as one of Philadelphia Business Journal’s Most Admired CEOs in 2015.

During the upcoming event both Ilyas and Doyle will discuss the foundation and take questions from the public about its goals and objectives.

To participate in the event and submit questions join us on Facebook Live July 28th at 7:00 PM. For more information on how to get involved click here.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version